Clinical Characteristics, Risk Factors and Outcomes of Invasive Fungal Disease in Critically III Patients with Hematological Malignancy: A Retrospective Study
Clinical Lymphoma Myeloma and Leukemia · 2025
DOI: 10.1016/j.clml.2024.12.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Changzhen Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Invasive Fungal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Guizhou Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Invasive fungal disease (IFD) poses significant challenges for critically ill patients with hematological malignancies (HMs). However, there is limited research on the clinical characteristics, risk factors, and outcomes of IFD within this population. METHOD: A retrospective study was conducted at a tertiary center in China. The study focused on patients with HMs admitted to the intensive care unit (ICU) between 2014 and 2022. RESULTS: A total of 239 patients were enrolled, among whom 105 (43.9%) were diagnosed with IFD. Further classification revealed that 64.8%, 31.4%, and 3.8% were classified as possible, probable, and proven IFD, respectively. Patients with IFD had significantly prolonged ICU stays compared to those without IFD (median: 4.9 vs. 2.9 days, P < .001). Notably, there was no statistically significant difference in 28-day mortality between the patients with and without IFD (44.8% vs. 54.5%, P = .907). Hypertension, mechanical ventilation (MV) duration exceeding 48 hours, and an extended interval between deterioration and ICU admission emerged as independent risk factors for IFD. CONCLUSION: IFD is a common complication in critically ill patients with HM and is associated with prolonged length of ICU stay. Additionally, hypertension, prolonged MV duration and delayed ICU transfer are independent risk factors of IFD in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Hematology, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Intensive Care Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Electronic address: 262347762@qq.com.
Förderung
- National Key Research and Development Program of China
- Guizhou Medical University
- National Natural Science Foundation of China
Zitieren
APA
Yang, C., Xiong, J., Wang, J., Bi, H., Fu, J., Liu, X., Long, C., Zhang, Q., He, D., Tang, Y., & Liu, X. (2025). Clinical Characteristics, Risk Factors and Outcomes of Invasive Fungal Disease in Critically III Patients with Hematological Malignancy: A Retrospective Study. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.12.005
Vancouver
Yang C, Xiong J, Wang J, Bi H, Fu J, Liu X, et al. Clinical Characteristics, Risk Factors and Outcomes of Invasive Fungal Disease in Critically III Patients with Hematological Malignancy: A Retrospective Study. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2024.12.005
BibTeX
@article{Yang2025,
author = {Yang, Changzhen and Xiong, Jie and Wang, Jiakai and Bi, Hongying and Fu, Jianyu and Liu, Xian and Long, Chun and Zhang, Qianfu and He, Dehua and Tang, Yan and Liu, Xu},
title = {Clinical Characteristics, Risk Factors and Outcomes of Invasive Fungal Disease in Critically III Patients with Hematological Malignancy: A Retrospective Study},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2025},
doi = {10.1016/j.clml.2024.12.005}
}
EUVIMED